Saluja, R.; Jiao, T.; Koshy, L.; Cheung, M.; Chan, K.K.W.
Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs. Curr. Oncol. 2021, 28, 606-618.
https://doi.org/10.3390/curroncol28010060
AMA Style
Saluja R, Jiao T, Koshy L, Cheung M, Chan KKW.
Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs. Current Oncology. 2021; 28(1):606-618.
https://doi.org/10.3390/curroncol28010060
Chicago/Turabian Style
Saluja, Ronak, Tina Jiao, Liza Koshy, Matthew Cheung, and Kelvin K. W. Chan.
2021. "Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs" Current Oncology 28, no. 1: 606-618.
https://doi.org/10.3390/curroncol28010060
APA Style
Saluja, R., Jiao, T., Koshy, L., Cheung, M., & Chan, K. K. W.
(2021). Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs. Current Oncology, 28(1), 606-618.
https://doi.org/10.3390/curroncol28010060